- Home
- ETNB vs CNNE Comparison
ETNB vs CNNE Comparison
Compare ETNB & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETNB
- CNNE
- Stock Information
- Founded
- ETNB 2018
- CNNE 2014
- Country
- ETNB United States
- CNNE United States
- Employees
- ETNB N/A
- CNNE N/A
- Industry
- ETNB Biotechnology: Pharmaceutical Preparations
- CNNE Restaurants
- Sector
- ETNB Health Care
- CNNE Consumer Discretionary
- Exchange
- ETNB Nasdaq
- CNNE Nasdaq
- Market Cap
- ETNB 1.2B
- CNNE 1.1B
- IPO Year
- ETNB 2019
- CNNE N/A
- Fundamental
- Price
- ETNB $7.34
- CNNE $18.32
- Analyst Decision
- ETNB Strong Buy
- CNNE Buy
- Analyst Count
- ETNB 10
- CNNE 2
- Target Price
- ETNB $27.56
- CNNE $22.50
- AVG Volume (30 Days)
- ETNB 2.1M
- CNNE 916.3K
- Earning Date
- ETNB 05-08-2025
- CNNE 05-08-2025
- Dividend Yield
- ETNB N/A
- CNNE 2.62%
- EPS Growth
- ETNB N/A
- CNNE N/A
- EPS
- ETNB N/A
- CNNE N/A
- Revenue
- ETNB N/A
- CNNE $452,500,000.00
- Revenue This Year
- ETNB N/A
- CNNE N/A
- Revenue Next Year
- ETNB N/A
- CNNE $2.01
- P/E Ratio
- ETNB N/A
- CNNE N/A
- Revenue Growth
- ETNB N/A
- CNNE N/A
- 52 Week Low
- ETNB $5.99
- CNNE $15.99
- 52 Week High
- ETNB $11.84
- CNNE $22.99
- Technical
- Relative Strength Index (RSI)
- ETNB 39.62
- CNNE 50.21
- Support Level
- ETNB $7.66
- CNNE $17.09
- Resistance Level
- ETNB $9.32
- CNNE $20.12
- Average True Range (ATR)
- ETNB 0.77
- CNNE 0.68
- MACD
- ETNB -0.04
- CNNE 0.23
- Stochastic Oscillator
- ETNB 9.04
- CNNE 56.42
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
About CNNE Cannae Holdings Inc.
Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.